CITED4 and pachyonychia congenita: Additionally, survival analysis using the Q-omics software showed a significant reduction in overall survival among PC patients who exhibited high CITED expression as compared to that in PC patients with low CITED4 expression (Fig. 1I), indicating that CITED4 expression is associated with GEM resistance and poor prognosis.